Novel canonical and non-canonical viral antigens extend current targets for immunotherapy of HPV-driven cervical cancer.

导出 LinkOut

翻译打印收藏纠错

第一作者： Xu,Peng

第一单位： Centre for Immuno-Oncology, Nuffield Department of Medicine, University of Oxford, OX3 7DQ Oxford, UK.

作者： Xu,Peng ^[1] ; Isaac,Woodhouse ^[1] ; Gemma,Hancock ^[2] ; Robert,Parker ^[1] ; Kristina,Marx ^[3] ; Julius,Müller ^[4] ; Silvia,Salatino ^[3] ; Thomas,Partridge ^[5] ; Annalisa,Nicastri ^[2] ; Hanqing,Liao ^[1] ; Gary,Kruppa ^[3] ; Karin,Hellner ^[1] ; Lucy,Dorrell ^[3] ; Nicola,Ternette ^[4]

作者单位： Centre for Immuno-Oncology, Nuffield Department of Medicine, University of Oxford, OX3 7DQ Oxford, UK. ^[1] Nuffield Department of Medicine, University of Oxford, OX3 7FZ Oxford, UK. ^[2] The Jenner Institute, University of Oxford, OX3 7DQ Oxford, UK. ^[3] Bruker Daltonics, Fahrenheitstraße 4, 28359 Bremen, Germany. ^[4] Wellcome Centre Human Genetics, University of Oxford, OX3 7BN Oxford, UK. ^[5] Nuffield Department of Women's and Reproductive Health, University of Oxford, John Radcliffe Hospital, OX3 9DU Oxford, UK. ^[6] Immunocore Ltd., OX14 4RY Abingdon, UK. ^[7]

关键词 Cancer Cell biology Immunology

DOI 10.1016/j.isci.2023.106101

PMID 36876126

发布时间 2024-04-30

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览1

iScience

2023年26卷3期

106101页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Novel canonical and non-canonical viral antigens extend current targets for immunotherapy of HPV-driven cervical cancer.

iScience

相似文献

iScience

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Novel canonical and non-canonical viral antigens extend current targets for immunotherapy of HPV-driven cervical cancer.

iScience

相似文献

iScience

相关期刊

检索历史清除